Luigi Formisano

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 14

Top Topics

Metastatic Breast Cancer

Tyrosine Kinase

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

International journal of molecular sciences

NPJ breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Angel L Guerrero-Zotano, Stefania Belli, Christoph C Zielinski, Juan Miguel Gil-Gil, Antonio Fernandez-Serra, Manuel Ruiz Borrego, Eva Ciruelos Gil, Javier Pascual, Montserrat Muñoz, Begoña Bermejo, Mireia Margelí, Antonio Antón-Torres, Laura Murillo, Bella Nisenbaum, Yuan Liu, Jesus Herranz, Daniel Fernandez-Garcia, Rosalía Caballero, Jose Antonio Lopez-Guerrero, Roberto Bianco, Luigi Formisano, Nicholas C Turner, Miguel Martin
CCNE1 and PLK1 mediates resistance to palbociclib in HR+/HER2- metastatic breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Fabrizio Di Costanzo, Fabiana Napolitano, Fabio Salomone, Anna Rita Amato, Gennaro Alberico, Fortuna Migliaccio, Giovanna Pecoraro, Annachiara Marra, Felice Crocetto, Antonio Ruffo, Sarah Scagliarini, Sabrina Rossetti, Livio Puglia, Marilena Di Napoli, Roberto Bianco, Alberto Servetto, Luigi Formisano
Analysis of Health-Related Quality of Life Reporting in Phase III RCTs of Advanced Genitourinary Tumors. Cancers 15 (23) (2023)
Stefania Belli, Daniela Esposito, Alessandra Allotta, Alberto Servetto, Paola Ciciola, Ada Pesapane, Claudia M Ascione, Fabiana Napolitano, Concetta Di Mauro, Elena Vigliar, Antonino Iaccarino, Carmine De Angelis, Roberto Bianco, Luigi Formisano
Pak1 pathway hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer. NPJ breast cancer 9 (1) (2023)
Stefania Belli, Ada Pesapane, Alberto Servetto, Daniela Esposito, Fabiana Napolitano, Claudia Maria Ascione, Alessandra Allotta, Nicola Zambrano, Federica Zito Marino, Renato Franco, Teresa Troiani, Luigi Formisano, Roberto Bianco
Combined blockade of mTOR and p21-activated kinases pathways prevents tumour growth in KRAS-mutated colorectal cancer. British journal of cancer (2023)
Roberto Buonaiuto, Fabiana Napolitano, Sara Parola, Pietro De Placido, Valeria Forestieri, Giovanna Pecoraro, Alberto Servetto, Luigi Formisano, Pietro Formisano, Mario Giuliano, Grazia Arpino, Sabino De Placido, Carmine De Angelis
Insight on the Role of Leptin: A Bridge from Obesity to Breast Cancer. Biomolecules 12 (10) (2022)
Pasquale Pisapia, Antonino Iaccarino, Caterina De Luca, Gennaro Acanfora, Claudio Bellevicine, Roberto Bianco, Bruno Daniele, Luisa Ciampi, De Felice Marco, Teresa Fabozzi, Luigi Formisano, Pasqualina Giordano, Cesare Gridelli, Giovanni Pietro Ianniello, Annamaria Libroia, Paolo Maione, Mariantonia Nacchio, Fabio Pagni, Giovanna Palmieri, Francesco Pepe, Gianluca Russo, Maria Salatiello, Antonio Santaniello, Rachele Scamarcio, Davide Seminati, Michele Troia, Giancarlo Troncone, Elena Vigliar, Umberto Malapelle
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy. International journal of molecular sciences 23 (15) (2022)
Jyoti Chauhan, Sathyaraj Aasaithambi, Ivan Marquez-Rodas, Luigi Formisano, Sophie Papa, Nicolas Meyer, Andrea Forschner, Guy Faust, Mike Lau, Alexandros Sagkriotis
Understanding the Lived Experiences of Patients With Melanoma: Real-World Evidence Generated Through a European Social Media Listening Analysis. JMIR cancer 8 (2) (2022)
Vincenzo De Falco, Stefania Napolitano, Daniela Esposito, Luigi Pio Guerrera, Davide Ciardiello, Luigi Formisano, Teresa Troiani
Comprehensive Review on the Clinical Relevance of Long Non-Coding RNAs in Cutaneous Melanoma. International journal of molecular sciences 22 (3) (2021)
Alberto Servetto, Antonio Santaniello, Fabiana Napolitano, Francesca Foschini, Roberta Marciano, Eleonora Mozzillo, Priscilla Cascetta, Anna Rita Amato, Maria Rosaria Augurio, Lucia Maresca, Pietro De Placido, Sabino De Placido, Luigi Formisano, Roberto Bianco
Use of FOLFIRINOX or Nab-Paclitaxel Plus Gemcitabine for the Treatment of Locally Advanced Pancreatic Adenocarcinoma: A Single Institution Observational Study. Cancers 13 (19) (2021)
Alberto Servetto, Rahul Kollipara, Luigi Formisano, Chang-Ching Lin, Kyung-Min Lee, Dhivya R Sudhan, Paula I Gonzalez Ericsson, Sumanta Chatterjee, Angel L Guerrero-Zotano, Saurabh Mendiratta, Hiroaki Akamatsu, Nicholas James, Roberto Bianco, Ariella B Hanker, Ralf Kittler, Carlos L Arteaga
Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER+ Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (15) (2021)
Stefania Belli, Daniela Esposito, Alberto Servetto, Ada Pesapane, Luigi Formisano, Roberto Bianco
c-Src and EGFR Inhibition in Molecular Cancer Therapy: What Else Can We Improve? Cancers 12 (6) (2020)
Paola Ciciola, Priscilla Cascetta, Cataldo Bianco, Luigi Formisano, Roberto Bianco
Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents. Journal of clinical medicine 9 (3) (2020)
Carlo Buonerba, Simona Iaccarino, Pasquale Dolce, Martina Pagliuca, Michela Izzo, Luca Scafuri, Ferdinando Costabile, Vittorio Riccio, Dario Ribera, Brigitta Mucci, Simone Carrano, Fernanda Picozzi, Davide Bosso, Luigi Formisano, Roberto Bianco, Sabino De Placido, Giuseppe Di Lorenzo
Predictors of Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Receiving EGFR Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis. Cancers 11 (9) (2019)
Antonio Santaniello, Fabiana Napolitano, Alberto Servetto, Pietro De Placido, Nicola Silvestris, Cataldo Bianco, Luigi Formisano, Roberto Bianco
Tumour Microenvironment and Immune Evasion in EGFR Addicted NSCLC: Hurdles and Possibilities. Cancers 11 (10) (2019)